Skip to main content
SpringerLink
Log in

Prognostic value of cell-cycle markers in ocular adnexal lymphoma: an assessment of 230 cases

  • Laboratory Investigation
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

Background

To determine the prognostic value of cell-cycle associated markers in ocular adnexal lymphoma (OAL).

Methods

Two hundred sixty-one consecutive cases of ocular adnexal lymphoproliferative lesions were subdivided into reactive lymphoid hyperplasia (RLH), atypical lymphoid hyperplasia (ALH) and OAL. The latter were sub-typed according to the new WHO Lymphoma Classification. All lesions were investigated applying standard immunohistochemical methods with antibodies specific for pRB, p53, p16, p21, BCL-6 and for multiple myeloma oncogene-1-protein (MUM1, also known as IRF4). The main endpoints included the development of a local recurrence, of systemic disease and of lymphoma-related death. The association of prognostic variables with endpoints was assessed by multiple logistic and Cox regression models, respectively.

Results

The ocular adnexal lymphoproliferative lesions were categorised as OAL (n=230; 88%), RLH (n=29; 11%), and ALH (n=2; 1%). The major lymphoma subtypes included 136 extranodal marginal zone B-cell lymphoma (EMZL), 31 diffuse large cell B-cell lymphomas, 27 follicular lymphomas, 9 plasmacytomas, 9 lymphoplasmocytic lymphoma/immunocytomas and 8 mantle cell lymphomas. The median follow-up time was 44.5 months. Most OAL patients had Stage IE disease and were treated with radiotherapy. Thirty-seven (25%) Stage IE patients had tumour relapses: these were significantly associated with an increased BCL6 blast percentage. Sixty-two (42%) Stage IE patients developed systemic disease: they had “non-EMZL” with large growth fractions and increased blast percentages for BCL6. Fifty-seven (25%) OAL patients died because of their lymphoma; lymphoma-related death was significantly associated on multivariable analysis with advanced clinical stage, an age >60 years and large tumour growth fractions.

Conclusion

Subtyping of OAL according to the new WHO Lymphoma Classification, the stage of disease and tumour cell growth fraction aided the prediction of (1) tumour relapse, (2) the development of systemic disease and (3) lymphoma-related death in OAL.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9

Similar content being viewed by others

References

  1. A Malignancy Study Group of T-and B-Cells (1985) Statistical analyses of clinico-pathological, virological and epidemiological data on lymphoid malignancies with special reference to adult T-cell leukemia/lymphoma: a report of the second nationwide study of Japan. Jpn J Clin Oncol 15:517–535

    Google Scholar 

  2. Anagnostopoulos I, Stein H (2000) Large B-cell lymphomas: variants and entities. Pathologe 21:178–189

    Article  CAS  PubMed  Google Scholar 

  3. Auw-Haedrich C, Coupland SE, Kapp A, et al (2001) Long term outcome of ocular adnexal lymphoma subtyped according to the REAL classification. Br J Ophthalmol 85:63–69

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Baldini L, Blini M, Guffanti A, et al (1998) Treatment and prognosis in a series of primary extranodal lymphomas of the ocular adnexa. Ann Oncol 9:779–781

    Article  CAS  PubMed  Google Scholar 

  5. Bastard C, Deweindt C, Kerckaert JP, et al (1994) LAZ3 rearrangements in non-Hodgkin’s lymphoma: correlation with histology, immunophenotype, karyotype, and clinical outcome in 217 patients. Blood 83:2423–2427

    CAS  PubMed  Google Scholar 

  6. Bennett CL, Putterman A, Bitran JD, et al (1986) Staging and therapy of orbital lymphomas. Cancer 57:1204–1208

    Article  CAS  PubMed  Google Scholar 

  7. Bessell EM, Henk JM, Wright JE, Whitelocke RA (1988) Orbital and conjunctival lymphoma treatment and prognosis. Radiother Oncol 13:237–244

    Article  CAS  PubMed  Google Scholar 

  8. Cordell JL, Falini B, Erber WN, et al (1984) Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 32:219–229

    Article  CAS  PubMed  Google Scholar 

  9. Coupland SE, Krause L, Delecluse HJ, et al. (1998) Lymphoproliferative lesions of the ocular adnexa. Analysis of 112 cases. Ophthalmology 105:1430–1441

    Article  CAS  PubMed  Google Scholar 

  10. Coupland SE, Foss HD, Assaf C, et al (1999) T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases. Ophthalmology 106:2109–2120

    Article  CAS  PubMed  Google Scholar 

  11. Coupland SE, Hummel M, Stein H (2002) Ocular adnexal lymphomas: five case presentations and a review of the literature. Surv Ophthalmol 47:470–490

    Article  PubMed  Google Scholar 

  12. Dierlamm J, Pittaluga S, Stul M, et al (1997) BCL6 gene rearrangements also occur in marginal zone B-cell lymphoma. Br J Haematol 98:719–725

    Article  CAS  PubMed  Google Scholar 

  13. Falini B, Fizzotti M, Pucciarini A, et al (2000) A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells. Blood 95:2084–2092

    CAS  PubMed  Google Scholar 

  14. Hardman Lea S, Kerr Muir M, Wotherspoon AC, et al. (1994) Mucosal-associated lymphoid tissue lymphoma of the conjunctiva. Arch Ophthalmol 112:1207–1212

    Article  Google Scholar 

  15. Harris NL, Isaacson PG (1999) What are the criteria for distinguishing MALT from non-MALT lymphoma at extranodal sites? Am J Clin Pathol 111:S126–S132

    CAS  PubMed  Google Scholar 

  16. Harris NL, Jaffe ES, Stein H, et al (1994) A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group (see comments). Blood 84:1361–1392

    CAS  PubMed  Google Scholar 

  17. Harris NL, Stein H, Coupland SE, et al (2001) New approaches to lymphoma diagnosis. Hematology (Am Soc Hematol Educ Program):194–220

  18. Hsu SM, Raine L, Fanger H (1981) Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29:577–580

    Article  CAS  PubMed  Google Scholar 

  19. Isaacson P, Wright DH (1983) Malignant lymphoma of mucosa-associated lymphoid tissue: a distinctive type of B-cell lymphoma. Cancer 52:1410–1416

    Article  CAS  PubMed  Google Scholar 

  20. Jaffe ES, Harris NL, Stein H, Vardiman JW (2001) World Health Organization classification of tumours. Tumours of haematopoietic and lymphoid tissues. Pathology and genetics. IARC Press, Lyon

  21. Jakobiec FA, Knowles DM (1989) An overview of ocular adnexal lymphoid tumors. Trans Am Ophthalmol Soc 87:420–444

    CAS  PubMed  PubMed Central  Google Scholar 

  22. Jenkins C, Rose GE, Bunce C, et al (2000) Histological features of ocular adnexal lymphoma (REAL classification) and their association with patient morbidity and survival. Br J Ophthalmol 84:907–913

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Johnson TE, Tse DT, Byrne GE, Jr., et al (1999) Ocular-adnexal lymphoid tumors: a clinicopathologic and molecular genetic study of 77 patients. Ophthal Plast Reconstr Surg 15:171–179

    Article  CAS  PubMed  Google Scholar 

  24. Knowles DM (ed) (2001) Neoplastic hematopathology, 2nd edn. Lippincott, Williams and Wilkins, Philadelphia

  25. Knowles DM, Jakobiec FA, McNally L, Burke JS (1990) Lymphoid hyperplasia and malignant lymphoma occurring in the ocular adnexa (orbit, conjunctiva, and eyelids): a prospective multiparametric analysis of 108 cases during 1977 to 1987. Hum Pathol 21:959–973

    Article  CAS  PubMed  Google Scholar 

  26. Korkolopoulou PA, Angelopoulou MK, Kontopidou FN, et al (2001) Retinoblastoma gene product and P21 (WAF1, CIP1) protein expression in non Hodgkin’s lymphomas: a multivariate survival analysis. Leuk Lymphoma 40:647–658

    Article  CAS  PubMed  Google Scholar 

  27. Mannami T, Yoshino T, Oshima K, et al (2001) Clinical, histopathological, and immunogenetic analysis of ocular adnexal lymphoproliferative disorders: characterization of malt lymphoma and reactive lymphoid hyperplasia. Mod Pathol 14:641–649

    Article  CAS  PubMed  Google Scholar 

  28. Martinez JC, Piris MA, Sanchez-Beato M, et al (1993) Retinoblastoma (Rb) gene product expression in lymphomas. Correlation with Ki67 growth fraction. J Pathol 169:405–412

    Article  CAS  PubMed  Google Scholar 

  29. McKelvie PA, McNab A, Francis IC, et al (2001) Ocular adnexal lymphoproliferative disease: a series of 73 cases. Clin Experiment Ophthalmol 29:387–393

    Article  CAS  PubMed  Google Scholar 

  30. Medeiros LJ, Harris NL (1989) Lymphoid infiltrates of the orbit and conjunctiva. A morphologic and immunophenotypic study of 99 cases. Am J Surg Pathol 13:459–471

    Article  CAS  PubMed  Google Scholar 

  31. Nakata M, Matsuno Y, Katsumata N, et al (1999) Histology according to the Revised European-American Lymphoma Classification significantly predicts the prognosis of ocular adnexal lymphoma. Leuk Lymphoma 32:533–543

    Article  CAS  PubMed  Google Scholar 

  32. Norton AJ, Jordan S, Yeomans P (1994) Brief, high-temperature heat denaturation (pressure cooking): a simple and effective method of antigen retrieval for routinely processed tissues. J Pathol 173:371–379

    Article  CAS  PubMed  Google Scholar 

  33. Omonishi K, Yoshino T, Sakuma I, et al. (1998) bcl-6 protein is identified in high-grade but not low-grade mucosa-associated lymphoid tissue lymphomas of the stomach. Mod Pathol 11:181–185

    CAS  PubMed  Google Scholar 

  34. Sasai K, Yamabe H, Dodo Y, et al (2001) Non-Hodgkin’s lymphoma of the ocular adnexa. Acta Oncol 40:485–490

    Article  CAS  PubMed  Google Scholar 

  35. Shields CL, Shields JA, Carvalho C, et al (2001) Conjunctival lymphoid tumors: clinical analysis of 117 cases and relationship to systemic lymphoma. Ophthalmology 108:979–984

    Article  CAS  PubMed  Google Scholar 

  36. Shih LY, Liang DC (1991) Non-Hodgkin’s lymphomas in Asia. Hematol Oncol Clin North Am 5:983–1001

    CAS  PubMed  Google Scholar 

  37. Sigelman J, Jakobiec FA (1978) Lymphoid lesions of the conjunctiva: relation of histopathology to clinical outcome. Ophthalmology 85:818–843

    Article  CAS  PubMed  Google Scholar 

  38. Smitt MC, Donaldson SS (1993) Radiotherapy is successful treatment for orbital lymphoma. Int J Radiat Oncol Biol Phys 26:59–66

    Article  CAS  PubMed  Google Scholar 

  39. Stefanaki K, Tzardi M, Kouvidou C, et al (1998) Expression of p53, p21, mdm2, Rb, bax and Ki67 proteins in lymphomas of the mucosa-associated lymphoid (MALT) tissue. Anticancer Res 18:2403–2408

    CAS  PubMed  Google Scholar 

  40. Takeshita M, Iwashita A, Kurihara K, et al (2000) Histologic and immunohistologic findings and prognosis of 40 cases of gastric large B-cell lymphoma. Am J Surg Pathol 24:1641–1649

    Article  CAS  PubMed  Google Scholar 

  41. Villuendas R, Sanchez-Beato M, Martinez JC, et al (1998) Loss of p16/INK4A protein expression in non-Hodgkin’s lymphomas is a frequent finding associated with tumor progression. Am J Pathol 153:887–897

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. White WA, Ferry JA, Harris NL, Grove AS (1995) Ocular adnexal lymphoma. A clinicopathologic study with identification of lymphomas of mucosa-associated lymphoid tissue type. Ophthalmology 102:1994–2006

    Article  CAS  PubMed  Google Scholar 

  43. Wotherspoon AC, Diss TC, Pan LX, et al (1993) Primary low-grade B-cell lymphoma of the conjunctiva: a mucosa-associated lymphoid tissue type lymphoma. Histopathology 23:417–424

    Article  CAS  PubMed  Google Scholar 

  44. Ye BH, Lista F, Lo Coco F, et al (1993) Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma. Science 262:747–750

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, University Hospital Benjamin Franklin of the Free University, Hindenburgdamm 30, 12200, Berlin, Germany

    Sarah E. Coupland & Harald Stein

  2. Department of Medical Statistics, Informatics and Epidemiology, University of Cologne, Cologne, Germany

    Martin Hellmich

  3. Department of Ophthalmology, University Hospital Freiburg, Freiburg, Germany

    Claudia Auw-Haedrich

  4. Department of Pathology, Western Infirmary, Glascow, Scotland

    William R. Lee

Authors
  1. Sarah E. Coupland
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Martin Hellmich
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Claudia Auw-Haedrich
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. William R. Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Harald Stein
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sarah E. Coupland.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Coupland, S.E., Hellmich, M., Auw-Haedrich, C. et al. Prognostic value of cell-cycle markers in ocular adnexal lymphoma: an assessment of 230 cases. Graefe's Arch Clin Exp Ophthalmol 242, 130–145 (2004). https://doi.org/10.1007/s00417-003-0831-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-003-0831-5

Keywords

Search

Navigation